Title of Session: Who Am I Now? Integrating the Cancer Identity into the Self
Speakers: Dr. Tamara Vesel, Chief of Division of Palliative Care, Clinical Associate Professor of Medicine and Pediatrics, Tufts University School of Medicine and Dr. Maeve Baechler, LIFE Cancer Coaching
Date: Saturday, May 14, 2022
Time: 11:00 AM to 12:30 PM Eastern Time (US and Canada)
Dr. Tamara Vesel and Dr. Maeve Baechler will be facilitating the discussion and exploring questions such as:
Please register in advance for this session. After registering, you will receive a confirmation email containing more information and the Zoom meeting link.
Get email alerts about the latest treatments, research advances, and opportunities to get involved.
The planned Phase 1 clinical trial includes patients with tumor types with a high frequency of Hippo pathway alterations, including NF2-deficient malignant mesothelioma and some soft tissue sarcomas with YAP/TAZ genetic fusions, including Epithelioid Hemangioendothelioma (EHE), a rare form of soft tissue sarcoma that has a significant unmet medical need with no currently approved therapy […]Read More
As the season of giving and gratefulness is upon us, we want to thank you for being a part of The EHE Foundation family. We appreciate you following our progress and investing in our passion: discovering effective treatments and a cure for EHE. We are thankful for our supporters, partners, and volunteers who make our […]Read More
Thank you to our wonderful participants, supporters, and sponsors for making our 2021 EHE Fun Run and Walk a tremendous success! Together, more than 900 supporters across the nation helped raise more than $45,000. Thanks to the backing of our sponsors, every penny brought in for this event will go directly to EHE research. This […]Read More
FOR IMMEDIATE RELEASEContact: Medha Deoras-Sutliff, firstname.lastname@example.org Hobart, Wisconsin. (October 12, 2021) — The EHE Foundation announced today that it has received a $1 million award from the Margie and Robert E. Petersen Foundation to drive forward progress towards treatments and a cure for Epithelioid Hemangioendothelioma (EHE), a rare vascular cancer. This support provides capacity-building resources […]Read More